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Significance of the Study
• Our aim was to improve the 50% detection rate of ultrasonographic fetal biometry in the diagnosis of 
intrauterine growth restriction (IUGR). This study shows that the correlation between placental vol-
ume and birth weight is strong and that the umbilical artery lumen area is decreased in IUGR. Among 
the maternal blood parameters, only the platelet count correlates with clinical findings. The evaluation 
of these data can make the diagnosis more accurate.
DOI: 10.1159/000497240
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Abstract
Objective: To investigate the placental and umbilical cord 
histopathology in intrauterine growth restriction (IUGR) and 
their relation to second-trimester maternal hematological 
parameters. Materials and Methods: Patients were selected 
for the IUGR group based on estimated fetal weight below 
the 10th percentile. Patients were recruited into the control 
group randomly. Patients were followed up with ultrasound, 
and blood samples were taken between the 20th and 24th 
gestational weeks. After delivery and formalin fixation, 
weight and volume of the placenta were recorded and his-
tologic samples were processed. Results: Maternal platelet 
count strongly correlates with placental weight (r = 0.766). 
On the other hand, neonatal weight correlates with placen-
tal volume (r = 0.572) rather than with placental weight (r = 
0.469). Umbilical arterial lumen cross-sectional area corre-
lates with birth weight (r = 0.338). Conclusions: Maternal he-
matological parameters do not seem to affect neonatal out-
come. Our main findings are the correlation of maternal 
platelet count with placental weight, the correlation of pla-
cental volume with birth weight being stronger than the cor-
relation of placental weight with birth weight, and the cor-
relation of umbilical artery lumen cross-sectional area with 
neonatal weight. Mild histopathologic alterations might oc-
cur in normal pregnancies; however, sufficient fetal nutrition 
can be maintained. This compensatory function of the pla-
centa seems to be insufficient when two or more patholo-
gies are present, which is characteristic for IUGR.
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Introduction
Intrauterine growth restriction (IUGR) increases peri-
natal mortality by 10–25% and morbidity by 50–75% and 
predisposes the newborn to metabolic syndrome, diabe-
tes mellitus, stroke, and heart disease. The placental mi-
crovasculature is essential for the sufficient transfer of 
gases, nutrients, and metabolites between the mother and 
the fetus [1]. The size, weight, and shape of the placenta 
may vary within wide extreme values, and placental size 
is related to its ability to transfer nutrients [1, 2]. The re-
lationship between placental morphometry and adverse 
pregnancy outcome, including IUGR, is known [3]. Small 
placental size, decreased placental surface area [4], and 
small placental volume [5] have been associated with in-
creased risk of IUGR. Placental weight increases linearly 
as gestation progresses and its capacity to transfer me-
tabolites increases and compensates for its slow growth 
related to fetal development. Weight and volume of pla-
centas associated with IUGR are lower than that of their 
normal-weight counterparts [6]. Placental coefficients 
(placental weight/fetal weight ratio) between 0.10 and 
0.18 are considered normal. The literature is not consis-
tent regarding overall placental volume. In some cases, as 
the functioning placental tissue tries to compensate for 
the reduced circulation, the placental weight might not be 
reduced in IUGR [7]. Placentas of infants with IUGR are 
characterized by smaller diameters, increased placental 
coefficient, and decreased placental weight and volume as 
compared to that of normal-weight infants [8]. It is not 
clear yet how placental weight and volume are related. 
Sonographically, placental volume can be used to detect 
placental growth restriction that precedes fetal IUGR by 
several weeks [9]. There are placental vascular patholo-
gies (calcification, reduced capillarization in the terminal 
villi, reduced cytotrophoblast proliferation, chronic vil-
litis, infarcts, perivillous fibrin deposition, etc.) that are 
associated with growth restriction, the presence of which 
does not explain how low birth weight and mild forms are 
present in normal pregnancies too [10].
Placental function can be assessed in vivo by uteropla-
cental Doppler flow velocimetry, and fetal growth can be 
assessed by serial ultrasonic biometry. The flow velocity 
waveform in the umbilical artery normally shows low re-
sistance in the last trimester of pregnancy, and this is 
thought to reflect the development of the villous vascular 
tree [11]. High resistance in the umbilical artery is widely 
used as an indicator of placental dysfunction, where the 
elevation of resistance correlates with the maldevelop-
ment of the tertiary villi [1]. Low-for-gestational-age fe-
tuses show abnormal blood flow velocity waveforms in 
the umbilical and uterine artery with reduced, absent, or 
reverse diastolic flow and abnormally reduced blood flow 
per unit of fetal weight. IUGR remains a diagnostic chal-
lenge, as ultrasound provides a detection rate of only 50%. 
The explanation for low detection rate might be that bi-
ometry and flowmetry does not give direct information 
about the ratio of functional/pathological placental tis-
sue, it provides information only indirectly [12].
Maternal hemoglobin level (Hgb) might be another 
marker in IUGR screening. High placental coefficient 
with low maternal Hgb suggests differences in placental 
growth related to fetal growth [13]. Although severe ane-
mia is associated with IUGR, maternal iron status cannot 
be assessed simply from Hgb concentration because plas-
ma volume is increased in pregnancy and Hgb concentra-
tion decreases accordingly. The failure of the plasma vol-
ume to expand itself might cause growth restriction too 
[14]. Mean corpuscular volume of red blood cells does 
not change substantially during pregnancy; therefore, it 
might be a better choice for predicting adverse fetal out-
come [14]. Yet there is no sufficient evidence of a rela-
tionship between placental ratio, Hgb concentration, or 
mean corpuscular volume [15]. Other studies report that 
the decrease in Hgb concentration in pregnancy is related 
to birth weight; failure of the Hgb concentration to fall 
below 105 g/L indicates an increased risk of low birth 
weight and preterm delivery [16]. High blood viscosity, 
elevated platelet count, and spontaneous platelet aggrega-
tion can be risk factors for vascular occlusions and a nov-
el risk factor for adverse pregnancy outcomes such as pre-
eclampsia and IUGR too [17]. Most studies on the inter-
relationships between antenatal uteroplacental Doppler 
blood flow velocimetry and the postnatal findings have 
focused on the microscopic and ultrastructural character-
istics of the placenta [18] or the relationship between fetal 
weight and the gross morphology of the placenta [19].
The objective of this study was to evaluate pathological 
changes of the placenta and umbilical cord in connection 
with IUGR pregnancies and to investigate whether birth 
weight or placental changes are influenced by maternal 
hematologic blood parameters. 
Materials and Methods
Study Design
Pregnant subjects were recruited in a prospective case-control 
study between January 2014 and December 2016 in the Department 
of Obstetrics and Gynecology, University of Szeged, Szeged, Hun-
gary. Each subject signed informed consent in accordance with the 
Placental and Umbilical Cord 
Histopathology
103Med Princ Pract 2019;28:101–108
DOI: 10.1159/000497240
Declaration of Helsinki and was followed up until delivery. Clinical 
data were collected from the medical anamnesis, blood parameters 
were taken in the second trimester, between the 24th and 30th weeks 
of gestation. Subjects were classified into the IUGR group if the es-
timated fetal weight on the 20th week of gestation was below the 10th 
percentile as per race, gender, and gestational age, and recruited into 
the control group randomly. For birth weight percentile, we used the 
sex-specific percentile scale of the International Society of Ultra-
sound in Obstetrics and Gynecology [20]. Patients with twin preg-
nancies, preterm births, genetic malformations, chromosomal or 
developmental disorders, hypertension (< 140/80 Hg mm), diabetes 
(fasting plasma glucose < 6.9 mmol/L measured at the 24th week of 
gestation), alcohol, nicotine or drug abuse were excluded from the 
study. Patients involved in the study did not have immunological, 
cardiovascular, gastrointestinal, or pulmonary disease.
Data Collection
Every ultrasound examination was performed by the same per-
son to avoid interobserver variability. All patients were scanned in 
a semi-recumbent position. The factorial default setting “Obstet-
rics/2–3 trimester” was used in 2-D mode on a GE Voluson 730 
machine. Gestational age was determined based on the first day of 
the last menstrual period and on ultrasound biometry (crown-
rump length and biparietal diameter) between the 9th and 11th 
weeks of pregnancy. In the 20th–24th week, fetal biometry was 
used to assess estimated fetal weight by the formula B of Hadlock 
[21]. A conventional color Doppler study of the umbilical arteries 
were also performed and the S/D ratio was read from report dis-
play of ultrasound. After delivery, the weight of the neonate and 
placental volume were measured. For volume measurements, we 
used the water replacement technique.
Umbilical Cord and Placental Sample Processing
After 3–7 days of formalin fixation, placental weight and vol-
ume were measured and gross examination of the placenta and the 
umbilical cord was executed by an expert pathologist according to 
the Guideline of The Royal College of Pathologists, 2011 [22]. Af-
ter measuring the diameters, the placenta was cut along the longest 
diameter in 1-cm-thick strips using a brain knife and the thickness 
of the tissue was measured at the umbilical cord insertion. Um-
bilical cord samples were taken from the placental end and cut into 
transversal slices of 4 mm, perpendicular to the umbilical cord. 
The slices were dehydrated in graded ethanol series, cleaned in xy-
lene, and embedded in paraffin. Paraffin samples were sectioned 
at 4 μm. After hematoxylin/eosin (HE) staining, histologic samples 
were analyzed via Axio Vision SE64 Rel. 4.9.1. microscope. The 
following parameters of the umbilical cord were measured in dig-
itized HE-stained sections; umbilical cord longest cross-sectional 
diameter, vessel lumen area, and vessel wall thickness. Because of 
the umbilical cord coiling, the surface of the vessels were not math-
Table 1. Clinical data of the mothers and newborns
IUGR (n = 8) Control (n = 46) p
mean ±SD mean ±SD
MCV, fL 84.48 0.96 88.25 1.26 ns
RBC, T/L 4.07 0.03 4.03 0.10 ns
Hgb, g/L 123.80 4.48 121.50 2.31 ns
Htk, L/L 0.35 0.01 0.36 0.01 ns
PLT, ×109/L 235.50 24.73 197.80 11.81 ns
MPV, fL 10.65 0.66 12.01 0.32 ns
Prothrombin time, s 12.80 0.10 12.93 0.13 ns
INR 0.97 0.01 0.98 0.01 ns
APTT, s 33.93 0.26 32.03 0.47 ns
Umbilical artery S/D 3.39 0.38 2.22 0.11 0.0006
Maternal age, years 29.75 1.11 25.72 3.64 ns
Maternal BMI 28.48 2.35 22.46 1.83 ns
Parity 0.85 0.16 1.48 0.34 ns
Birth weight, g 2,110.00 194.0 3,367.73 435.04 0.0023
Gestational age, weeks 37.29 1.10 38.58 1.58 ns
1-min Apgar score 7.71 1.14 8.38 1.85 0.036
5-min Apgar score 8.86 1.46 9.46 1.13 ns
10-min Apgar score 9.57 1.13 9.92 0.28 ns
Male, % 50.00 – 45.94 – ns
Female, % 50.00 – 54.05 – ns
Maternal peripheral venous blood parameters: MCV, mean corpuscular volume of red blood cells; RBC, red 
blood cell count; Hgb, hemoglobin; Htk, hematocrit; PLT, platelet count; MPV, mean platelet volume; INR, 
international normalized ratio; APTT, activated partial thromboplastin time; BMI, body mass index; S/D, systolic 
and diastolic blood flow velocity ratio; ns, not significant.
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ematically perfect cross-sections, and we standardized our mea-
surements to the highest point of torsion, lowest point of torsion, 
and an extra measurement at the 3, 6, or 9 o’clock position depend-
ing on the first two points. Placental histological samples (3 mm × 
10 mm × 20 mm) were taken from the umbilical cord insertion, the 
edge of the placenta, the fetal and maternal side of the placenta, 
and from the pathological alteration(s), if there were any.
Statistical Analysis
For normally distributed maternal and neonatal characteris-
tics and outcomes of the umbilical cord and placenta, we used t 
test, and analysis of variance (ANOVA) was applied to assess dif-
ferences in vessel wall thickness depending on different lumen 
shapes in arteries. The Kruskal-Wallis test was applied to skewed 
variables with Bonferroni correction. Differences were considered 
statistically significant at p < 0.05. After a multiparametric corre-
lation analysis with post hoc adjustment for multiple compari-
sons, linear regression analysis was applied to investigate the re-
lationships among maternal blood parameters and clinical out-
come. Correlation was evaluated as “strong” if the value of r was 
above 0.5, “moderate” between 0.3 and 0.5, and “weak” under 0.3. 
All analyses were performed via Prism 6 (Graph Pad Software 
Inc., San Diego, CA, USA).
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Fig. 1. Placental morphometry; placental volume measured after delivery (a) shows the strongest correlation with 
birth weight, not the placental volume (b) or weight (c) after formalin fixation.
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Results
Fifty-four patients (46 controls, 8 IUGR) were recruit-
ed. Clinical data and maternal blood parameters are 
shown in Table 1. Values of mean corpuscular volume of 
red blood cells (r = 0.0487), red blood cell count (r = 
0.0147), Hgb (r = 0.1098), hematocrit (r = 0.0016), plate-
let count (r = 0.0009), prothrombin time (r = 0.0048), INR 
(r = 0.0148), or activated partial thromboplastin time (r = 
0.0240) did not correlate with neonatal weight. Platelet 
count showed a strong correlation with placental weight 
(r = 0.7660). Gross pathological examination revealed 
that placental volume measured right after delivery shows 
the strongest correlation with birth weight rather than 
with placental weight or with volume after formalin fixa-
tion (Fig. 1). The results of histological examination are 
shown in Tables 2 and 3. The prevalence of obliterated, 
star-shaped lumen in one or both arteries did not differ 
in the IUGR or control cases (Fig. 2), but the lumen cross-
sectional area shows a mild correlation with birth weight 
(r = 0.336). We found non-conversion of maternal arter-
ies in the placenta that is similar to that of the uterine ar-
teries seen via ultrasound as end-diastolic stop of blood 
flow (notch). The five cases did not coincide with notch 
in uterine arteries in our ultrasonographic data on uterine 
arteries.
IUGR 
(n = 8)
Control 
(n = 46)
n % n %
Focal calcification 2 25.00 5 10.87
Villous hypovascularization 4 50.00 2 4.35
Villous hypoplasia 4 50.00 7 15.22
Intervillous fibrin deposition 3 37.50 5 10.87
Syncytial node 3 37.50 1 2.17
Amnion nodosum 0 0.00 1 2.17
Villitis 0 0.00 1 2.17
Hematoma 0 0.00 2 4.35
Non-conversion of maternal vessels 2 25.00 3 6.52
Table 3. Umbilical cord and placental pathology
IUGR (n = 8) Control (n = 46) p
mean ±SD mean ±SD
Vena umbilicalis vessel wall thickness, µm 663.8 41.6 605.4 20.6 ns
Vena umbilicalis lumen area, µm2 1,563,000.0 1,054,000.0 1,803,000.0 514,365.0 ns
Arteria umbilicalis vessel wall thickness, µm 636.4 41.0 678.2 15.0 ns
Arteria umbilicalis lumen area, µm2 146,825.0 18,369.0 526,659.0 77,690.0 0.0296
Ratio of star-shaped arteries 0.71 0.29 0.89 0.13 ns
UCI 1.05 0.27 1.52 0.44 ns
Umbilical cord diameter, mm 93.20 8.34 116.10 6.24 ns
Number of placental pathologies present 2.13 0.30 0.70 0.11 <0.0001
Native placental volume, mL 315.30 23.44 492.50 17.95 <0.0001
Placental volume after formalin fixation, mL 368.80 23.15 461.50 15.01 0.0018
Placental weight after formalin fixation, g 401.80 18.33 468.90 15.49 0.0226
Longest placental diameter, cm 15.50 1.15 15.86 0.20 ns
Shortest placental diameter, cm 13.11 0.46 14.39 0.29 0.0196
Placental thickness, cm 2.58 0.14 2.71 0.08 ns
Placental coefficient 1.19 0.01 0.14 0.01 <0.0001
Table 2. Placental histopathologic alter-
ations
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Discussion
This study shows that the correlation between placental 
volume and birth weight is stronger than the correlation 
between placental weight and birth weight. The umbilical 
artery lumen area is significantly decreased in IUGR preg-
nancies. Among the maternal peripheral venous blood pa-
rameters, only the platelet count correlates with the clinical 
findings. Other blood parameters that could alter maternal 
blood viscosity seem to have no effect on fetal weight. 
Blood samples were taken between the 20th and 24th weeks 
of gestation, right after when the placental vascular tree had 
developed and the ultrasonographically measurable sings 
of placental malperfusions were detectable.
The results draw attention to antenatally measurable 
possible predictors of intrauterine growth restriction, the 
placental volume, the shortest diameter of placenta, and 
the lumen area of umbilical arteries in IUGR. The strength 
of this study is that each kind of measurement was per-
formed blindly and by only one researcher. A limitation 
of this study is the small number of cases. In our clinic, 
the annual birth rate is about 2,300, and IUGR pregnan-
cies with known etiologic backgrounds (other than pla-
cental insufficiency) were excluded.
Elevated numbers of maternal mononuclear cells and 
increased levels of cytokines have been reported in pre-
eclampsia, and also the cytokine levels produced is high-
er. The high proinflammatory cytokine concentration 
may cause endothelial dysfunction and thus vasocon-
strictions [23]. We excluded pregnant patients with pre-
eclampsia or hypertension, and in connection with intra-
uterine growth restriction, we did not observe the same 
correlation. Based on the data collected from maternal 
hematologic parameters in our study, we would not sug-
gest them for further studies of predictors of low birth 
weight. Only the platelet count shows a correlation with 
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Fig. 2. Placental and umbilical cord histopathology; normal pla-
cental tissue (a) with vascularized villi and intrauterine growth-
restricted placental tissue (b) with hypovascularization and inter-
villous fibrin deposition (HE, 200×). Different coiling patterns 
(c) that can distort vessel cross-section and an obliterated, star-
shaped umbilical artery lumen (d) with perivascular hematoma 
and asymmetrical vessel wall (HE, 400×). Perivascular hematoma 
is the result of intrapartum pulling of the umbilical cord.
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clinical findings and it does not affect birth weight. In 
contrast with the cellular compounds of the maternal 
blood, cytokines and tumor necrosis factor alpha levels 
might be worth measuring in IUGR pregnancies [23, 24].
Our data shows that placental volume measured after 
delivery has a stronger correlation with birth weight than 
does placental weight with birth weight. Although these 
parameters differ significantly between the two groups, 
they do not reflect functional variability within the tissue. 
In a large placental disc with confluent infarctions, calcifi-
cation would still be in the upper range of weight and vol-
ume but would belong to a growth-restricted fetus. We rec-
ommend the development of a reliable in utero method to 
estimate functional placental volume that refines the esti-
mated fetal weight. We also suggest establishments of per-
centile curves of trimmed placental weights to be used for 
predicting growth restriction. The placental volume can be 
estimated by ultrasound more accurately than by placental 
weight [13]. Placental volume and shape also can be deter-
mined via medical resonance imaging (MRI). MRI gives 
additive information about the textural features and shape 
of the placenta. Placentas in IUGR pregnancies tend to be 
more oval and thicker than placentas of healthy fetuses, 
which are more circular [25]. Our morphologic measure-
ments support these observations. Some studies managed 
to establish a percentile curve placental volume. After some 
routinely performable measurements, new diagnostic ref-
erence values could be used [26]. Three-dimensional pla-
cental measurements in the first trimester showed a mod-
erate correlation with fetal weight. Measurements in the 
second trimester performed along the fetal side of the pla-
centa have better predictive values (up to 45%) and can be 
used for screening patients at high risk [27]. 
Our results confirm that mild histopathologic altera-
tions might be present in normal pregnancies, and until 
there is enough functional placental tissue, sufficient fetal 
nutrition can be maintained [13]. This compensatory re-
sidual of the placenta becomes insufficient when two or 
more pathologies are present, which is characteristic for 
IUGR. We have found non-conversion of the arteries in the 
maternal side of the placenta. The five cases did not coin-
cide with notch in uterine arteries. With a mathematical 
model, it has been demonstrated that the vessel wall shear 
stress and blood velocity jets are bigger in uterine arteries 
in IUGR and also vortices occur more often in the intervil-
lous space [28]. This condition of increased turbulence 
with increased platelet count promotes the formation of 
microthrombus that explains the intervillous deposition of 
fibrin and increased placental weight related to birth weight 
in IUGR pregnancies. Umbilical vessels are coiling togeth-
er along the cord and their cross-section perpendicular to 
the longitudinal axis of the cords will rarely be a true math-
ematical cross-section. This artefact causes torsion, oval or 
bean-shaped lumen, and variability in measurements of 
vessel wall thickness. In cases of strict arterial constriction, 
a star-shaped lumen can be seen. To overcome this adver-
sity, we standardized our method based on this torsion and 
performed an additional measurement semi-independent-
ly. This method is reproducible in ultrasonography. Only 
the lumen cross-sectional area of the umbilical arteries dif-
fered between the IUGR and control group. Our finding of 
non-significantly decreased arterial vessel wall thickness 
conforms to the published literature [29, 30].
Conclusion
The novelty of our study is the correlation of maternal 
platelet count with placental weight, the stronger correla-
tion of placental volume with birth weight than the cor-
relation of placental weight with birth weight, and the 
correlation of umbilical artery lumen cross-sectional area 
and neonatal weight. Larger studies are needed to ascer-
tain whether these alterations in umbilical arteries are 
part of a fetal response to undernutrition or the etiology 
of part of IUGR. Further studies are also needed to estab-
lish a diagnostic method involving similar findings to in-
crease the accuracy of predicting fetal outcome.
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